Clinical Trial Update: Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating the efficacy and safety of Kinerase for treatment of cutaneous facial photodamage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging

Drugs mentioned

• Kinerase

Snippet

Sponsor: Menarini (Thailand) Limited | Conditions: Skin Roughness, Mottling | Phase 4 | Status: COMPLETED